| Primary |
| Drug Use For Unknown Indication |
29.9% |
| Atrial Fibrillation |
26.4% |
| Product Used For Unknown Indication |
13.9% |
| Cardiac Failure |
7.3% |
| Hypertension |
5.6% |
| Arrhythmia |
3.4% |
| Congestive Cardiomyopathy |
1.6% |
| Cardiac Disorder |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Hypothyroidism |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Angina Pectoris |
1.0% |
| Essential Hypertension |
1.0% |
| Prophylaxis |
1.0% |
| Anticoagulant Therapy |
0.8% |
| Cardiac Failure Congestive |
0.8% |
| Supraventricular Tachycardia |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Diabetes Mellitus |
0.6% |
| Heart Rate Irregular |
0.6% |
|
| Vomiting |
15.7% |
| Therapeutic Agent Toxicity |
15.2% |
| Medication Error |
7.6% |
| Death |
6.6% |
| Nausea |
5.1% |
| Syncope |
5.1% |
| Overdose |
4.5% |
| Product Quality Issue |
4.0% |
| Visual Impairment |
4.0% |
| Bradycardia |
3.5% |
| Drug Ineffective |
3.5% |
| Somnolence |
3.5% |
| Cardioactive Drug Level Increased |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Visual Disturbance |
3.0% |
| Weight Decreased |
3.0% |
| Heart Rate Increased |
2.5% |
| Loss Of Consciousness |
2.5% |
| Nodal Arrhythmia |
2.5% |
| Completed Suicide |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.7% |
| Depression |
13.9% |
| Diabetes Mellitus |
12.0% |
| Product Used For Unknown Indication |
9.9% |
| Atrial Fibrillation |
8.8% |
| Hypertension |
6.5% |
| Tachyarrhythmia |
5.9% |
| Cardiac Failure |
4.3% |
| Dyslipidaemia |
2.4% |
| Cardiac Failure Chronic |
2.1% |
| High Density Lipoprotein Decreased |
2.1% |
| Cardiac Failure Congestive |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Cardiac Disorder |
1.7% |
| Ill-defined Disorder |
1.6% |
| Hypothyroidism |
1.4% |
| Arrhythmia |
1.3% |
| Cardiomyopathy |
1.3% |
| Self Injurious Behaviour |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
|
| Vomiting |
12.8% |
| Death |
11.2% |
| Myocardial Infarction |
11.2% |
| Syncope |
8.0% |
| Pneumonia |
5.6% |
| Therapeutic Agent Toxicity |
5.6% |
| Weight Decreased |
4.8% |
| Bradycardia |
4.0% |
| Overdose |
4.0% |
| Dyspnoea |
3.2% |
| Hyponatraemia |
3.2% |
| Hypotension |
3.2% |
| Renal Disorder |
3.2% |
| Renal Failure Acute |
3.2% |
| Respiratory Arrest |
3.2% |
| Sinus Bradycardia |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Cardiac Failure Congestive |
2.4% |
| Dizziness |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.1% |
| Drug Use For Unknown Indication |
20.2% |
| Atrial Fibrillation |
10.0% |
| Hypertension |
7.4% |
| Cardiac Disorder |
3.8% |
| Diabetes Mellitus |
3.3% |
| Pain |
2.9% |
| Cardiac Failure Congestive |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Pulmonary Arterial Hypertension |
1.9% |
| Depression |
1.8% |
| Osteoporosis |
1.8% |
| Type 2 Diabetes Mellitus |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Multiple Myeloma |
1.7% |
| Cardiac Failure |
1.6% |
| Hormone Replacement Therapy |
1.5% |
| Prophylaxis |
1.4% |
| Pulmonary Hypertension |
1.3% |
|
| Vomiting |
11.9% |
| Weight Decreased |
9.7% |
| Death |
9.1% |
| Myocardial Infarction |
8.1% |
| Weight Increased |
6.3% |
| Transient Ischaemic Attack |
5.1% |
| Nausea |
4.7% |
| Pain |
4.6% |
| Oedema Peripheral |
4.4% |
| Dyspnoea |
4.2% |
| International Normalised Ratio Increased |
3.9% |
| Urinary Tract Infection |
3.6% |
| Vision Blurred |
3.6% |
| Sepsis |
3.4% |
| Pneumonia |
3.2% |
| Renal Failure Acute |
3.1% |
| Renal Failure |
2.9% |
| Syncope |
2.8% |
| Unevaluable Event |
2.8% |
| Drug Ineffective |
2.6% |
|
| Interacting |
| Diabetes Mellitus |
23.4% |
| Depression |
22.4% |
| Tachyarrhythmia |
11.2% |
| Atrial Fibrillation |
6.5% |
| Dyslipidaemia |
5.6% |
| Essential Hypertension |
5.6% |
| High Density Lipoprotein Decreased |
5.6% |
| Blood Cholesterol Increased |
3.7% |
| Product Used For Unknown Indication |
3.7% |
| Drug Use For Unknown Indication |
2.8% |
| Angina Pectoris |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Hypertensive Heart Disease |
1.9% |
| Parkinson's Disease |
1.9% |
| Hypokalaemia |
0.9% |
| Palpitations |
0.9% |
|
| Myocardial Infarction |
50.0% |
| Drug Interaction |
16.7% |
| Volume Blood Decreased |
16.7% |
| Drug Ineffective |
8.3% |
| Toxicity To Various Agents |
8.3% |
|